Sartorius

Sartorius

Sartorius collaborates with the life sciences and biopharmaceutical sectors, supporting research and manufacturing advancements.

HQ location
Göttingen, Germany
Launch date
Market cap
$21.9b
Enterprise value
$24.3b
Share price
202.80 DIM.PA
Company register number
HRB 1970 (Göttingen)

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2021202220232024202520262027
Revenues0000000000000000000000000000
% growth51 %21 %(21 %)-7 %11 %12 %
EBITDA0000000000000000000000000000
% EBITDA margin29 %35 %25 %25 %30 %32 %33 %
Profit0000000000000000000000000000
% profit margin14 %25 %11 %6 %12 %13 %15 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue4 %4 %5 %5 %---

Source: Company filings or news article, Equity research estimates

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo
Investments analysisEdit

Investments by Sartorius

Edit
Polyplus-transfection
ACQUISITION by Sartorius Mar 2023
BIA Separations
ACQUISITION by Sartorius Nov 2020
Essen Bioscience
ACQUISITION by Sartorius Mar 2017
MKS Umetrics
ACQUISITION by Sartorius Apr 2017
MatTek Corp.
ACQUISITION by Sartorius Apr 2025
Xell
ACQUISITION by Sartorius Aug 2021
CellGenix
ACQUISITION by Sartorius Jul 2021
Albumedix
ACQUISITION by Sartorius Aug 2022
WaterSep BioSeparations
ACQUISITION by Sartorius Dec 2020
View 1 more